Virtu KCG Holdings’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$172K Buy
16,821
+12,674
+306% +$130K ﹤0.01% 2219
2017
Q1
$48K Buy
4,147
+3,393
+450% +$39.3K ﹤0.01% 2833
2016
Q4
$10K Buy
+754
New +$10K ﹤0.01% 3269
2016
Q3
Sell
-4,442
Closed -$47K 3658
2016
Q2
$47K Buy
+4,442
New +$47K ﹤0.01% 2678
2016
Q1
Sell
-5,204
Closed -$138K 3514
2015
Q4
$138K Buy
+5,204
New +$138K ﹤0.01% 2371
2015
Q3
Sell
-2,810
Closed -$90K 3492
2015
Q2
$90K Buy
2,810
+698
+33% +$22.4K ﹤0.01% 2444
2015
Q1
$67K Buy
2,112
+1,525
+260% +$48.4K ﹤0.01% 2247
2014
Q4
$22K Buy
+587
New +$22K ﹤0.01% 2680
2014
Q3
Sell
-3,508
Closed -$104K 3261
2014
Q2
$104K Buy
3,508
+1,361
+63% +$40.3K ﹤0.01% 2274
2014
Q1
$80K Buy
2,147
+697
+48% +$26K ﹤0.01% 2073
2013
Q4
$60K Sell
1,450
-948
-40% -$39.2K ﹤0.01% 2342
2013
Q3
$127K Buy
+2,398
New +$127K ﹤0.01% 2228